​

Funding Round

Post-IPO Equity - Cartesian Therapeutics

Post-IPO Equity - Cartesian Therapeutics

Investment Firm

Overview

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

Announced Date

Jul 02, 2024

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorTimothy A. Springer
Participant InvestorSchooner Capital
Participant InvestorHBM Healthcare Investments
Participant InvestorInvus

Round Details and Background

Cartesian Therapeutics raised $130000000 on 2024-07-02 in Post-IPO Equity

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2016
Venture Round - Cartesian Therapeutics
1-undefined
May 04, 2021
Grant - Cartesian Therapeutics
1-2.0M
Jul 02, 2024
Post-IPO Equity - Cartesian Therapeutics
5-130.0M

Recent Activity

There is no recent news or activity for this profile.